GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entero Therapeutics Inc (FRA:366) » Definitions » Other Gross PPE

Entero Therapeutics (FRA:366) Other Gross PPE : €0.19 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Entero Therapeutics Other Gross PPE?

Entero Therapeutics's Other Gross PPE for the quarter that ended in Mar. 2024 was €0.19 Mil.

Entero Therapeutics's quarterly Other Gross PPE increased from Sep. 2023 (€0.03 Mil) to Dec. 2023 (€0.21 Mil) but then declined from Dec. 2023 (€0.21 Mil) to Mar. 2024 (€0.19 Mil).

Entero Therapeutics's annual Other Gross PPE declined from Dec. 2021 (€0.32 Mil) to Dec. 2022 (€0.27 Mil) and declined from Dec. 2022 (€0.27 Mil) to Dec. 2023 (€0.21 Mil).


Entero Therapeutics Other Gross PPE Historical Data

The historical data trend for Entero Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entero Therapeutics Other Gross PPE Chart

Entero Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.09 0.32 0.27 0.21

Entero Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.03 0.21 0.19

Entero Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Entero Therapeutics (FRA:366) Business Description

Traded in Other Exchanges
Address
777 Yamato Road, Suite 502, Boca Raton, FL, USA, 33431
First Wave BioPharma Inc is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. It is advancing a therapeutic development pipeline populated with multiple clinical-stage programs built around its two proprietary technologies-niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.

Entero Therapeutics (FRA:366) Headlines

No Headlines